Rituximab and Escalated Chemotherapy in Elderly Patients with Aggressive Diffuse Large-Cell Lymphoma: A Controlled Clinical Trial
Author:
Affiliation:
1. Oncology Research Unit, Oncology Hospital, National Medical Center, IMSS, México, D.F. Mexico
2. The Department of Hematology, Oncology Hospital, National Medical Center, IMSS, México, D.F. Mexico
Publisher
Mary Ann Liebert Inc
Subject
Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Link
http://www.liebertpub.com/doi/pdf/10.1089/cbr.2006.360
Reference25 articles.
1. Aggressive lymphoma in the elderly
2. 8 Malignant lymphoma in the elderly
3. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.
4. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.
5. Full Dose Chop Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era;Leukemia & Lymphoma;2018-04-04
2. Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline;Clinical Oncology;2017-01
3. Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents;Supportive Care in Cancer;2016-06-25
4. Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma;Archives of Medical Research;2015-08
5. Rituximab as Consolidation Therapy Did Not Improve Outcome in Patients with Diffuse Large B-Cell Lymphoma at Complete Response After Dose-Dense Chemotherapy (CHOP-14);Cancer Biotherapy and Radiopharmaceuticals;2015-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3